The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Automotive
  • Technology
  • Arts
  • Human resources

Important July 11, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Oscar Health, Inc. Investors of Securities Fraud Class Action Lawsuit
The PennZone/10187928

Trending...
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • Heritage at South Brunswick's Townhome Models Coming Soon!
  • SprintRay Retainers Available in Allentown from Exeter Smiles
RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Oscar Health, Inc. (Oscar) (NYSE: OSCR). The action charges Oscar with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Oscar's materially misleading statements to the public, Oscar investors have suffered significant losses.

CLICK HERE TO SUBMIT YOUR OSCAR LOSSES. YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/new-cases/oscar-health-inc?utm_source=PR&utm_medium=link&utm_campaign=oscar_health&utm_campaign=oscr&mktm=r

More on The PennZone
  • Cody Keller Bookkeeping Empowers Harrisburg Entrepreneurs with Stress-Free Financial Management
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
  • Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development
  • Axiros North America Announces New CEO: Gabriel Davidov
  • CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns

TO VIEW OUR VIDEO, PLEASE CLICK HERE

LEAD PLAINTIFF DEADLINE: JULY 11, 2022

CLASS PERIOD: PURSUANT AND/OR TRACEABLE TO OSCAR'S MARCH 2021 IPO THROUGH MAY 12, 2022

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS
:
James Maro, Esq. (484) 270-1453 or Toll Free (844) 887-9500 or Email at info@ktmc.com

Kessler Topaz is one of the world's foremost advocates in protecting the public against corporate fraud and other wrongdoing. Our securities fraud litigators are regularly recognized as leaders in the field individually and our firm is both feared and respected among the defense bar and the insurance bar. We are proud to have recovered billions of dollars for our clients and the classes of shareholders we represent.

OSCAR'S ALLEGED MISCONDUCT

In March, 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share. Oscar received net proceeds of approximately $1.3 billion from the IPO.

On August 12, 2021, Oscar disclosed that its Medical Loss Ratio (MLR) for the second quarter of 2021 was 82.4%, an increase of 2170 basis points year-over year, claiming that the increase was primarily driven by meaningfully lower utilization in 2Q20 as a result of COVID-19, as well as higher COVID-19 testing and treatment costs. Oscar also disclosed that its net loss for the quarter was $73.1 million, an increase of $32.1 million year-over-year.

Then, on November 10, 2021, Oscar disclosed that its third quarter 2021 MLR increased 920 basis points year-over-year, to 99.7%. Oscar claimed, again, that the MLR increase was primarily driven by higher net COVID costs, as well as several other purported reasons. Oscar also disclosed that its net loss for the quarter was $212.7 million, an increase of $133.6 million year-over-year.

Following this news, Oscar's share price fell $4.05 per share, or 24.5%, to close at $12.47 per share on November 11, 2021. At the time of the filing of the complaint, Oscar stock has traded as low as $5.76 per share, a more than 85% decline from the $39.00 per share IPO price.

WHAT CAN I DO?

Oscar investors may, no later than July 11, 2022 seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. Kessler Topaz Meltzer & Check, LLP encourages Oscar investors who have suffered significant losses to contact the firm directly to acquire more information.

More on The PennZone
  • Now Is the Right Time: Kaltra Highlights Its Proven Replacement Microchannel Coils
  • How to Optimize Your Website for AI Search with DeepRank AI
  • New Free Science Bingo Cards Help Grade 1 Students Learn Through Play
  • DeployHub Joins Catalyst Campus SDA TAP Lab
  • Veterans Day 2025: Virginia Veterans Can Claim Free Words of Veterans Book Vouchers

CLICK HERE TO SIGN UP FOR THE CASE

WHO CAN BE A LEAD PLAINTIFF?


A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

Contacts

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
  • National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
  • Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
  • Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
  • Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
  • Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
  • Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG)
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Arc Longevity Sells Out Debut Women's Creatine Gummy
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • Phinge, Home of Netverse, Through its Extensive Software & Hardware Patent Portfolio, Shows Founder & CEO Robert DeMaio's Vision & Innovation
  • OddsTrader Reveals Early Favorites and Best Bets to Win March Madness 2026
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field
  • Heritage at South Brunswick's Townhome Models Coming Soon!
  • PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth
  • Boston Industrial Solutions Unveils New and Improved Natron® UV Screen Printing Ink
  • SprintRay Retainers Available in Allentown from Exeter Smiles
  • Genuine Smiles Unveils New User-Friendly Website
  • Nusign Global Launch Event Concludes Successfully, Embarking on a New International Chapter

Popular on PennZone

  • New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them - 389
  • Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum - 315
  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 273
  • Root Canal Specialist In Frederick Maryland Joins Pearlfection Dentistry
  • Some Music for Donald's Bad Day
  • Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
  • Heritage at South Brunswick Announces New Single-Family Home Collection
  • Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
  • Jaipur's Savista Retreat announces $299 all-inclusive nightly rate for two for the 2026 season, including meals and city-center transfers
  • Hiclean Tools Releases HCX2100 Electric Pressure Washer

Similar on PennZone

  • Brazil 021 Chicago Launches New Website and Expands with No-Gi Classes for All Levels
  • American Star Guard Unveils a Powerful Rebrand and Expanded Security Services Throughout Nevada
  • Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development
  • Award-Winning Author Zane Carson Carruth Featured in USA Today for Inspiring Mission to Nurture Young Hearts Through Storytelling
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
  • $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
  • Year-Round Deals for Customers With Square Signs
  • Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
  • Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us